Relay Therapeutics, Inc. - Common Stock (RLAY)
CUSIP: 75943R102
Q3 2020 13F Holders as of 30 Sep 2020
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 177,447,642
- Total 13F shares
- 84,683,348
- Share change
- +84,683,348
- Total reported value
- $3,603,495,710
- Price per share
- $42.59
- Number of holders
- 94
- Value change
- +$3,603,495,710
- Number of buys
- 94
Quarterly Holders Quick Answers
What is CUSIP 75943R102?
CUSIP 75943R102 identifies RLAY - Relay Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Newer quarter: Q4 2020
Recent filing periods for CUSIP 75943R102:
Top shareholders of RLAY - Relay Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of Relay Therapeutics, Inc. - Common Stock (RLAY) as of Q3 2020
As of 30 Sep 2020,
Relay Therapeutics, Inc. - Common Stock (RLAY) was held by
94 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
84,683,348 shares.
The largest 10 holders included
SB INVESTMENT ADVISERS (UK) LTD, TRV GP III, LLC, FMR LLC, Casdin Capital, LLC, BVF INC/IL, EcoR1 Capital, LLC, TRV GP IV, LLC, PERCEPTIVE ADVISORS LLC, Foresite Capital Management IV, LLC, and BlackRock Inc..
This page lists
94
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2020 vs Q4 2025 Across Filers
Q4 2025 holders
224
Q3 2020 holders
94
Holder diff
-130
| Investor | Q4 2025 Shares | Q3 2020 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q3 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.